Economics

• Financial Aid and Early Admissions at Selective Need-Blind Colleges, Economic Theory (2021)

I study a college-admissions model with two need-blind colleges and heterogeneous students. In a game in which colleges can choose a financial aid policy and either binding, nonbinding, or no early admissions, a unique equilibrium outcome exists. In equilibrium, the more prestigious and wealthier college is more selective, has a more generous financial aid policy, and offers nonbinding early admissions, whereas the other college offers a binding program. Compared to the counterfactual in which only regular admissions are offered, early admissions make the more prestigious college worse off, the other college better off, and students, in the aggregate, better off.

[PDF] [Online Appendix]

Public Health

• Cost-Effectiveness Analysis of the Drugs Reimbursed by the Mexican Public Health System for the Second-Line Treatment of PD-L1 Positive, Advanced Non-Small-Cell Lung Cancer (NSCLC), with C. Baptista, Value in Health, Vol. 20, No. 5, May 2017.

• Cost-Effectiveness Analysis of Poractant Alpha (200mg/kg daily) Compared to Beractant (100mg/kg daily), in Premature Infants with Respiratory Distress Syndrome, from the Mexican Institute of Social Security (IMSS) Perspective, with A. Paladio Hernandez, S. Murra-Anton and C. Baptista, Value in Health, Vol. 20, No. 5, May 2017.

• Cost-Effectiveness Analysis of Intravitreal Aflibercept Compared with Ranibizumab-PRN in Patients with Wet Age-Related Macular Degeneration (WAMD), Value in Health, Vol. 18, No. 7, November 2015.

• Cost-Minimization Analysis of Intravitreal Aflibercept Compared With Ranibizumab On-Label in Patients with Wet Age-Related Macular Degeneration (WAMD), Value in Health, Vol. 18, No. 7, November 2015.